CAJ | 학술논문

监测分化型甲状腺癌(DTC)患者术后131I治疗的辐射剂量并规范其辐射防护对DTC患者131I治疗后自身及周围人群的健康有重要意义.目前研究表明,131I治疗的DTC患者自身的辐射不良反应大多都能得到较有效地缓解和控制.只要能严格规范地遵守131I治疗DTC的辐射防护相关法规和建议,加强辐射剂量监测,并对患者、工作人员和患者家属进行适当的教育和指导,其对周围人群的辐射剂量都能达到和符合国际上的辐射防护规定.
감측분화형갑상선암(DTC)환자술후131I치료적복사제량병규범기복사방호대DTC환자131I치료후자신급주위인군적건강유중요의의.목전연구표명,131I치료적DTC환자자신적복사불량반응대다도능득도교유효지완해화공제.지요능엄격규범지준수131I치료DTC적복사방호상관법규화건의,가강복사제량감측,병대환자、공작인원화환자가속진행괄당적교육화지도,기대주위인군적복사제량도능체도화부합국제상적복사방호규정.
It is of great significance to monitor radiation dose and standardize radiation protection of differentiated thyroid carcinoma (DTC) patients after 131I treatment.It can protect patients and the surrounding people from radiation risks.The present study showed that the adverse reactions can be alleviated and controlled effectively in DTC patients after 131I treatment.The radiation dose of the surrounding people can be in line with the international radiation protection regulations,as long as the related laws and regulations of radiation protection in 131I treatment can be strictly obeyed,as well as the radiation dose is monitored and the right guidance and instructions are given to the patients,staff and family members.